VegOut Magazine

I stopped introducing myself by my job title and discovered I had no idea how to explain who I was without it, which is the kind of identity loss nobody tells you about

The moment I stopped leading with my career title, I discovered a silence where my identity used to be — and it turns out that silence is one of the most universal, least discussed experiences of ...

[Ad hoc announcement pursuant to Art. 53 LR] Roche's fenebrutinib confirms its potential as first and only BTK inhibitor for relapsing and primary progressive MS in …

FENhance 1 met its primary endpoint, showing investigational fenebrutinib significantly reduced relapses by 51% compared to ...
Le Lézard

AbbVie Announces Positive Topline Results from Phase 3 AFFIRM Study Evaluating SKYRIZI® (Risankizumab) Subcutaneous Induction in Patients with Crohn's Disease

AbbVie today announced positive topline results from the Phase 3, randomized, placebo-controlled, double-blind AFFIRM study evaluating the efficacy and safety of risankizumab (SKYRIZI®) subcutaneous ...
AlphaGalileo

Technological innovations and high-throughput applications of light-sheet microscopy

Light-sheet fluorescence microscopy (LSFM), with its innovative design of selective plane illumination and orthogonal ...

How to Access a Company's Annual Reports and SEC Filings

Discover how to access company financial reports and SEC filings through investor relations sections and the EDGAR database for informed investing.